Case Report: Post-traumatic splenosis and potential pitfall for PSMA-PET
Background18F-prostate specific membrane antigen (PSMA) PET is fast becoming the gold-standard in prostate cancer, both in staging of intermediate-/high-risk patients and in re-staging patients with biochemical failure. Several pitfalls of 18F-PSMA PET have been reported, and we report, to our best...
Main Authors: | Marina Nearchou, Elizabeth Georgiou, Alexis Vrachimis, Konstantinos Ferentinos, Iosif Strouthos |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Nuclear Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnume.2023.1319952/full |
Similar Items
-
[99cmTc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center
by: P. Werner, et al.
Published: (2020-05-01) -
99mTc-Sn-colloid SPECT/CT in thoracic splenosis after esophageal cancer surgery
by: Kishin Tokuyama, et al.
Published: (2024-01-01) -
Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry
by: Pete Tually, et al.
Published: (2024-12-01) -
Optimizing PSMA scintigraphy for resource limited settings – a retrospective comparative study
by: Olumayowa U. Kolade, et al.
Published: (2024-04-01) -
The efficacy of 99mTc-HYNIC-PSMA SPECT/CT in detecting primary lesions and metastasis in newly diagnosed prostate cancer
by: Taisong Wang, et al.
Published: (2023-06-01)